ExxonMobil Holdings Is Maintained at Buy by TD Cowen
Ratings actions from Benzinga: GMT) ExxonMobil Holdings Price Target Raised to $180.00/Share From $168.00 by TD CowenRatings actions from Benzinga
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
8 results loaded, newest first. End of these results.
Xometry price target raised to $120 from $110 by Rosenblatt
Rosenblatt raised its Xometry price target to $120.00 per share from $110.00, maintaining a Buy rating, per Benzinga.
Fed raises benchmark rate for first time since July 2023
The Federal Reserve lifted its benchmark interest rate to a 3.75% to 4% range in a unanimous vote on Wednesday, marking the first hike since July 2023. The move implies higher borrowing costs while boosting yields on cash and short-term fixed-income holdings.
Rising oil prices and Treasury yields pressure 60/40 portfolios
Rising oil prices and Treasury yields are pressuring traditional 60/40 portfolios, with U.S. crude at $90.75 and the 10-year Treasury yield near 4.77%.
Nasdaq slides as long-end yields pressure chip stocks
The Nasdaq 100 fell 1.7% as 30-year Treasury yields held at 5.30% and rate-hike bets eased, while the optical and AI-hardware complex sold off sharply.
XOM Price Target Raised
XOM price target increased to 168
How to Earn $500 a Month From Exxon Mobil Stock Ahead of Q2 Earnings
ExxonMobil Holdings Corporation (NYSE: XOM ) will release its second-quarter earnings report before the opening bell on Friday, July 31. Analysts expect the company to report quarterly earnings of $3.68 per share, up from $1.64 per share in the year-ago period. The consensus estimate for Exxon Mobil’s quarterly revenue
Ligand price target raised to $388 from $266 at BofA
BofA analyst Jason Zemansky raised the firm's price target on Ligand to $388 from $266 and keeps a Buy rating on the shares. Despite strong share performance, Ligand's growth opportunity remains underappreciated, with the XOMA acquisition expanding its royalty portfolio, diversification, scalability, and earnings poten